Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

FDA approves first new drug for liver cancer in decade

April 28, 2017 Medical Communications, Sales and Marketing Bayer, Stivarga, hepatocellular carcinoma, liver cancer

The FDA has announced that it has approved the first new treatment for hepatocellular carcinoma (HCC), a type of liver …
News

SAB Biotherapeutics moves to bolster board

April 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

SAB Biotherapeutics, a clinical-stage biopharmaceutical development company, announced that it had appointed Thorkil Kastberg Christensen to its Board of Directors. …
Appointment

Mental health: Time for a new kind of therapy?

April 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing mental health

It’s no secret that mental health is not taken as seriously as its physical counterpart. It has been an uphill …
Feature

Teva has another high profile role to fill

April 27, 2017 Sales and Marketing Eyal Desheh, Teva, Teva Pharmaceuticals

Teva’s gaps at the top level of its structure continue to build, as Eyal Desheh is set to leave his …
News

ABPI calls for a “world-class NHS” with 2017 General Election Manifesto

April 27, 2017 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Theresa May, general election

With Theresa May’s announcement of a snap election in earlier this month, the life sciences industry erupted into fiery discourse. …
News

AZ’s Tagrisso continues successes with EU approval

April 26, 2017 Research and Development, Sales and Marketing AstraZeneca, EU, European Commission, NSCLC, Tagrisso

More good news for AstraZeneca’s Tagrisso (osimertinib), as the company announces that the European Commission has granted the drug full …
News

FDA condemns 14 companies selling fraudulent cancer ‘cures’ online

April 26, 2017 Research and Development, Sales and Marketing Cancer, FDA

The FDA has struck out against a wave of companies offering cancer treatments online which fraudulently claim to be able …
News

Sanofi launches lawsuit against Mylan over “illegal business practices”

April 26, 2017 Research and Development, Sales and Marketing Auvi-Q, Mylan, Sanofi, epipen, lawsuit

In a move that is sure to pile even more pressure onto Mylan after the company’s recent woes, Sanofi has …
News

The May 2017 issue of Pharmafocus is now live!

April 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus

The latest edition of Pharmafocus is available to read now! In this issue we delve into pharma’s reaction to the …
News

Rasna Therapeutics appoints new CEO

April 25, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Rasna Therapeutics, the UK-based biotech that specialises in developing treatments for leukaemia, has announced the appointment of a new CEO. …
Appointment

Pharma industry calls for EMA relocation by June in open EFPIA letter

April 25, 2017 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA

Heads of research from 19 of the biggest players in the industry have called for a decision to be made …
News

EMA gives positive opinion on Biogen’s spinal muscular atrophy drug Spinraza

April 25, 2017 Manufacturing and Production, Sales and Marketing Biogen, Ionis, Spinraza, spinal muscular atrophy

Biogen has revealed that Spinraza (nusinersen), its treatment for spinal muscular atrophy (SMA) , has received a positive opinion from …
News

Five crucial facts about mental health

April 24, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, anxiety, depression, mental health, world health day

7 April marked this year’s World Health Day, and for 2017 the WHO selected depression as the annual focus. Prevalent …
Feature

Psoriasis drug Siliq will be cheapest in class, Valeant reveals

April 24, 2017 Sales and Marketing Siliq, Valeant, psoriasis

Canadian pharmaceutical firm Valeant has announced the list price for its psoriasis treat Siliq (brodalumab) will stand at $3,500 a …
News

Breakthrough multiple sclerosis research sheds light on cause of the disease

April 24, 2017 Research and Development, Sales and Marketing multiple sclerosis

Researchers from the Universities of Exeter and Alberta have identified a protein in the brain which they believe could be …
News
The Gateway to Local Adoption Series

Latest content

Major funding opportunity opens for early cancer diagnostics

September 4, 2026

Androlabs receives UK authorisation for new Testavan presentation

September 4, 2026

CEPI backs African-led Bundibugyo Ebola vaccine development

September 3, 2026

Cytomos appoints life sciences executive to board

September 2, 2026

Cell therapy partnership aims to bring liver disease treatment closer to US patients

September 1, 2026